AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15559871 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg daily
Number of subjects: 85
Study 15559871 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 20 mg daily
Number of subjects: 85
Study 11928160 — intervention group
Group type: EXPERIMENTAL
Intervention: Support group interventions co-led by peers and professionals
Number of subjects: 21
Study 11928160 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional facilitators
Number of subjects: 21
Study 11928160 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer facilitators
Number of subjects: 21
Study 9710357 — intervention group
Group type: EXPERIMENTAL
Intervention: hP-16 (10 pmol/kg/min)
Number of subjects: 6
Study 8062939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix 5 mg (group 1)
Number of subjects: 10
Study 8062939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetrorelix 3 mg (group 2)
Number of subjects: 10
Study 29648859 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 107
Study 29648859 — intervention group
Group type: EXPERIMENTAL
Intervention: Alliance focused therapy
Number of subjects: 107
Study 29648859 — intervention group
Group type: COMPARATOR
Intervention: Therapists' ratings of the alliance
Number of subjects: 107
Study 27062069 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy + lodenafil 80 mg/one tablet per week (Group 4)
Number of subjects: 56
Study 27062069 — intervention group
Group type: COMPARATOR
Intervention: Group psychotherapy (Group 2)
Number of subjects: 56
Study 27062069 — intervention group
Group type: COMPARATOR
Intervention: Lodenafil 80 mg/one tablet per week (Group 3)
Number of subjects: 56
Study 27062069 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 56
Study 26704522 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 0
Study 26704522 — intervention group
Group type: COMPARATOR
Intervention: MaxFib
Number of subjects: 0
Study 26704522 — intervention group
Group type: COMPARATOR
Intervention: QLF
Number of subjects: 0
Study 23868905 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab with trastuzumab plus docetaxel
Number of subjects: 0
Study 23868905 — intervention group
Group type: COMPARATOR
Intervention: Placebo with trastuzumab plus docetaxel
Number of subjects: 0
Study 20568384 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast, 5 mg
Number of subjects: 154
Study 20568384 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol, 50 microg
Number of subjects: 154
Study 18294411 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 microg kg(‐1) over 10 min at anaesthesia induction followed by 0.4‐0.8 microg kg(‐1) h(‐1) infusion during maintenance
Number of subjects: 24
Study 18294411 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 1 microg kg(‐1) over 1 min at anaesthesia induction followed by 0.2‐0.4 microg kg(‐1) min(‐1) infusion during maintenance
Number of subjects: 24
Study 16274834 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS 14803 (0.5-3 mg/kg, thrice weekly for 4 weeks)
Number of subjects: 28
Study 12846124 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 12846124 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (Evista)
Number of subjects: 0
Study 11030202 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week course of oral prednisolone (PSL, 0.5 mg/kg)
Number of subjects: 20
Study 11030202 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week course of oral prednisolone (PSL, 0.5 mg/kg)
Number of subjects: 20
Study 9010860 — intervention group
Group type: EXPERIMENTAL
Intervention: Camptosar (irinotecan)
Number of subjects: 0
Study 9010860 — intervention group
Group type: EXPERIMENTAL
Intervention: Hycamtin (topotecan)
Number of subjects: 0
Study 9010860 — intervention group
Group type: EXPERIMENTAL
Intervention: 9‐aminocamptothecin TM (9‐AC)
Number of subjects: 0
Study 9010860 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel)
Number of subjects: 0
Study 9010860 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncaspar
Number of subjects: 0
Study 8476408 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour therapy
Number of subjects: 0
Study 8476408 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0
Study 8476408 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic psychotherapy
Number of subjects: 0
Study 8476408 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training (attention placebo)
Number of subjects: 0
Study 3818148 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg
Number of subjects: 12
Study 3818148 — intervention group
Group type: COMPARATOR
Intervention: Pirenzepine 50 mg
Number of subjects: 12
Study 3818148 — intervention group
Group type: COMPARATOR
Intervention: Pirenzepine 50 mg plus Ranitidine 150 mg
Number of subjects: 12
Study 3818148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31326936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuff Leak Test (CLT) results communicated to the bedside physician
Number of subjects: 100
Study 31326936 — intervention group
Group type: COMPARATOR
Intervention: Cuff Leak Test (CLT) results not communicated to the treating physician
Number of subjects: 100
Study 29972003 — intervention group
Group type: EXPERIMENTAL
Intervention: jinhuobu needling technique
Number of subjects: 54
Study 29972003 — intervention group
Group type: COMPARATOR
Intervention: reinforcing needing technique achieved by rotating needle
Number of subjects: 54
Study 29972003 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (before and after treatment)
Number of subjects: 54
Study 26555329 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 2604
Study 26555329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2604
Study 26995808 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-based FDPs
Number of subjects: 16
Study 26995808 — intervention group
Group type: COMPARATOR
Intervention: Zirconia-based FDPs
Number of subjects: 16
Study 26995808 — intervention group
Group type: EXPERIMENTAL
Intervention: Both materials
Number of subjects: 16
Study 22581424 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate replacement before and at the time of SWL in Group I (n: 20)
Number of subjects: 40
Study 22581424 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL without any additional specific management for hypocitraturia in Group II (n: 20)
Number of subjects: 40
Study 22581424 — intervention group
Group type: COMPARATOR
Intervention: Normocitraturic cases as the control group (Group III; n: 20)
Number of subjects: 40
Study 21280296 — intervention group
Group type: EXPERIMENTAL
Intervention: Antistax at a daily dose of 360 mg
Number of subjects: 119
Study 21280296 — intervention group
Group type: EXPERIMENTAL
Intervention: Antistax at a daily dose of 720 mg
Number of subjects: 119
Study 18375876 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutch Geriatric Intervention Program (DGIP)
Number of subjects: 0
Study 18375876 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 16104439 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg isobaric ropivacaine
Number of subjects: 50
Study 16104439 — intervention group
Group type: COMPARATOR
Intervention: 8 mg isobaric ropivacaine plus 25 microg fentanyl
Number of subjects: 50
Study 12005465 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of standard parenteral nutrition (1.5-liter HPN formula, infused over 10 hours, approximately 25 kcal/kg/d with 30% lipid and 1.0 to 1.5 g/kg/d of protein)
Number of subjects: 5
Study 12005465 — intervention group
Group type: COMPARATOR
Intervention: No infusion
Number of subjects: 5
Study 12005465 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of standard parenteral nutrition
Number of subjects: 5
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary venous flow in hypertrophic cardiomyopathy patients
Number of subjects: 80
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of systolic to diastolic pulmonary venous flow velocity
Number of subjects: 80
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of velocity‐time integrals of both flow waves at atrial contraction
Number of subjects: 80
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial minimal volume
Number of subjects: 80
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic fraction
Number of subjects: 80
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary venous flow velocity pattern and left atrial size
Number of subjects: 80
Study 10099924 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudonormal mitral flow pattern
Number of subjects: 80
Study 7770303 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.15 mg/kg every 6 hours for 4 days)
Number of subjects: 173
Study 7770303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study 7770303 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone and Placebo
Number of subjects: 173
Study 2180230 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Shigella flexneri 2a and Shigella sonnei vaccine candidate strains with two virulence‐reducing markers
Number of subjects: 0
Study 2180230 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic lysates of vaccine candidate strains
Number of subjects: 0
Study 298355 — intervention group
Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 8
Study 298355 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 8
Study 31977888 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (CCR) 3 times a week for 8 weeks plus neurologic music therapy (NMT) techniques, performed 3 times a week for 8 weeks.
Number of subjects: 30
Study 31977888 — intervention group
Group type: COMPARATOR
Intervention: Conventional cognitive rehabilitation (CCR) 6 times a week for 8 weeks.
Number of subjects: 30
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric leg strength assessment at peak (7:00)
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric leg strength assessment at nadir (21:00)
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal variation in isometric leg strength
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-to-day variation in isometric leg strength
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric arm strength assessment at peak (7:00)
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric arm strength assessment at nadir (21:00)
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal variation in isometric arm strength
Number of subjects: 19
Study 31476879 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-to-day variation in isometric arm strength
Number of subjects: 19
Study 29759709 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent vasovagal syncope (VVS) patients
Number of subjects: 24
Study 27405522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment in groups for 1 year
Number of subjects: 112
Study 27405522 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 112
Study 27405522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment in groups
Number of subjects: 112
Study 25055821 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture for 8 weeks
Number of subjects: 560
Study 25055821 — intervention group
Group type: COMPARATOR
Intervention: Prucalopride (2 mg once daily) for 32 weeks
Number of subjects: 560
Study 21894485 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 20 mg
Number of subjects: 110
Study 21894485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 19505393 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose sublingual‐swallow therapy (SLIT)
Number of subjects: 40
Study 19505393 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 40
Study 19505393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 17476875 — intervention group
Group type: EXPERIMENTAL
Intervention: SkinFold Thickness (SKF)
Number of subjects: 41
Study 17476875 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI-based estimation
Number of subjects: 41
Study 17476875 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA using Lukaski formula
Number of subjects: 41
Study 17476875 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA using Segal formula
Number of subjects: 41
Study 16322140 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST) for approximately 6 months
Number of subjects: 127
Study 16322140 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 127
Study 12410756 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin therapy (with or without anticholinergic agents)
Number of subjects: 94
Study 12410756 — intervention group
Group type: COMPARATOR
Intervention: Control group (continent controls)
Number of subjects: 94
Study 12410756 — intervention group
Group type: EXPERIMENTAL
Intervention: NDE group (therapy‐resistant enuresis)
Number of subjects: 94
Study 9530788 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician evaluation
Number of subjects: 0
Study 9530788 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine evaluation (Spinoscope)
Number of subjects: 0
Study 9530788 — intervention group
Group type: COMPARATOR
Intervention: Overall accuracy (Clinician vs Machine)
Number of subjects: 0
Study 9530788 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine's expert system
Number of subjects: 0
Study 8914565 — intervention group
Group type: EXPERIMENTAL
Intervention: Various inspired fractions of oxygen before, during and after general anaesthesia
Number of subjects: 15
Study 8914565 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspired oxygen fraction
Number of subjects: 15
Study 2121203 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 200
Study 2121203 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen
Number of subjects: 200
Study 6101299 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurolept anesthesia
Number of subjects: 20
Study 6101299 — intervention group
Group type: COMPARATOR
Intervention: Enflurane anesthesia
Number of subjects: 20
Study 29650683 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO) 3 mg/m2 days 1, 4, and 7
Number of subjects: 0
Study 26194249 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 48
Study 26194249 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 48
Study 25528907 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated trousers
Number of subjects: 164
Study 25528907 — intervention group
Group type: COMPARATOR
Intervention: Untreated trousers
Number of subjects: 164
Study 25528907 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated trousers without cut protection lining
Number of subjects: 164
Study 25528907 — intervention group
Group type: COMPARATOR
Intervention: Untreated trousers without cut protection lining
Number of subjects: 164
Study 25528907 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin-treated trousers with cut protection lining
Number of subjects: 164
Study 25528907 — intervention group
Group type: COMPARATOR
Intervention: Untreated trousers with cut protection lining
Number of subjects: 164
Study 21574832 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% taurine-hydrated collagen membrane
Number of subjects: 16
Study 21574832 — intervention group
Group type: COMPARATOR
Intervention: Saline-hydrated collagen membrane
Number of subjects: 16
Study 20056195 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE)
Number of subjects: 255
Study 18928735 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive education about the disease, drug therapy, diet, and telephonic strengthening
Number of subjects: 103
Study 18928735 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 103
Study 15982148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 143
Study 15982148 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 143
Study 12809846 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 96
Study 12809846 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 96
Study 10999261 — intervention group
Group type: EXPERIMENTAL
Intervention: Active school days (outdoor recess and physical education class)
Number of subjects: 76
Study 10999261 — intervention group
Group type: COMPARATOR
Intervention: Restricted school days (indoor recess at a computer terminal, no physical education class)
Number of subjects: 76
Study 8607955 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic ear drops (suspension of polymyxin B sulfate, neomycin sulfate, and hydrocortisone)
Number of subjects: 533
Study 8607955 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated ear molds
Number of subjects: 533
Study 8607955 — intervention group
Group type: COMPARATOR
Intervention: No precautions (control group)
Number of subjects: 533
Study 8607955 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming (combined groups 1, 2, and 3)
Number of subjects: 533
Study 1995088 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone suppression test (DST) nonsuppression
Number of subjects: 77
Study 1995088 — intervention group
Group type: COMPARATOR
Intervention: Normal DST results
Number of subjects: 77
Study 6208248 — intervention group
Group type: EXPERIMENTAL
Intervention: neomycin (1 g/l) + bacitracin (50,000 IU/l) + clindamycin (900 mg/l)
Number of subjects: 90
Study 6208248 — intervention group
Group type: EXPERIMENTAL
Intervention: mezlocillin (4 g) + oxacillin (2 g) intravenously
Number of subjects: 90
Study 6208248 — intervention group
Group type: COMPARATOR
Intervention: no antibiotics
Number of subjects: 90
Study 6208248 — intervention group
Group type: EXPERIMENTAL
Intervention: none
Number of subjects: 90
Study 31535722 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral nerve-2 (PECS 2) block
Number of subjects: 80
Study 31535722 — intervention group
Group type: COMPARATOR
Intervention: Serratus plane block
Number of subjects: 80
Study 29913743 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Gynecological Treatment + Mensendieck Somatocognitive Therapy (MSCT)
Number of subjects: 40
Study 29913743 — intervention group
Group type: COMPARATOR
Intervention: Standard Gynecological Treatment (STGT)
Number of subjects: 40
Study 27170790 — intervention group
Group type: EXPERIMENTAL
Intervention: Community engagement and planning (CEP)
Number of subjects: 1018
Study 27170790 — intervention group
Group type: COMPARATOR
Intervention: Resources for services (RS)
Number of subjects: 1018
Study 26071233 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - initial visit with clinical history, electrocardiogram, instruction about pulse palpation and warning signs, and electrocardiogram every 6 months during a 2-year follow-up.
Number of subjects: 928
Study 26071233 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - standard care without the intervention.
Number of subjects: 928
Study 21875205 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-prediction intervention asking participants to predict their future acceptance of HBV vaccination.
Number of subjects: 1175
Study 20507380 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement with curettes
Number of subjects: 31
Study 20507380 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic device
Number of subjects: 31
Study 18337147 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (MgSO4) 0.1 mg/l (4g)
Number of subjects: 688
Study 18337147 — intervention group
Group type: COMPARATOR
Intervention: Isotonic 0.9% saline (placebo)
Number of subjects: 688
Study 15784715 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg daily)
Number of subjects: 32
Study 15784715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 15784715 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight restoration
Number of subjects: 32
Study 12056708 — intervention group
Group type: EXPERIMENTAL
Intervention: Eniluracil/5-fluorouracil (5-FU) regimen: 5-FU 1 mg/m2 twice daily + eniluracil 10 mg/m2 twice daily for 28 days
Number of subjects: 36
Study 10078606 — intervention group
Group type: EXPERIMENTAL
Intervention: TA-GW vaccine (300 microg)
Number of subjects: 42
Study 10078606 — intervention group
Group type: EXPERIMENTAL
Intervention: TA-GW vaccine (0, 3, 30 microg)
Number of subjects: 42
Study 10078606 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 microg)
Number of subjects: 42
Study 8575575 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg.day‐1 for 4 days)
Number of subjects: 28
Study 8575575 — intervention group
Group type: EXPERIMENTAL
Intervention: OKY‐046 (400 mg.day‐1 for 4 days)
Number of subjects: 28
Study 8575575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 8575575 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin and OKY‐046
Number of subjects: 28
Study 1817780 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation screws technique
Number of subjects: 2
Study 1817780 — intervention group
Group type: COMPARATOR
Intervention: Tension bolt technique
Number of subjects: 2
Study 1817780 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 2
Study 6874967 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape intervention for distressed couples
Number of subjects: 58
Study 6874967 — intervention group
Group type: EXPERIMENTAL
Intervention: Written feedback for distressed couples
Number of subjects: 58
Study 6874967 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention for distressed couples
Number of subjects: 58